This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.93% per year. These returns cover a period from January 1, 1988 through October 6, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
medical-devices: Archive
NVDA & PLTR Driving AI in Health: Top Health IT Stocks for Q3 Earnings
by Urmimala Biswas
NVDA and PLTR drive AI integration across healthcare, fueling optimism for Omnicell and Tempus AI's Q3 performance.
NVDAPositive Net Change OMCLNegative Net Change ORCLNegative Net Change PLTRPositive Net Change TEMNegative Net Change
artificial-intelligence earnings medical medical-devices robotics smart-health tech-stocks
Hims & Hers Gains 3.8% in 3 Months: Time to Hold the Stock or Sell?
by Debanjana Dey
HIMS expands into men's health and hormones, but rising costs and regulatory hurdles threaten its momentum.
TDOCNegative Net Change AMWLPositive Net Change HIMSNegative Net Change
medical medical-devices
STXS Partners With CardioFocus to Boost Robotic Pulsed Field Ablation
by Zacks Equity Research
Stereotaxis partners with CardioFocus to commercialize the first robotic Pulsed Field Ablation system, aiming to revolutionize cardiac arrhythmia treatment.
MASINegative Net Change MMSIPositive Net Change STXSPositive Net Change WSTNegative Net Change
medical medical-devices
Here's How Quest Diagnostics Is Placed Ahead of Q3 Earnings
by Zacks Equity Research
DGX is poised for solid Q3 2025 results, backed by strong DIS growth, strategic M&A and robust test demand across key health segments.
DGXPositive Net Change IDXXNegative Net Change ANIPPositive Net Change EXASNegative Net Change
earnings medical medical-devices
HOLX's Enhanced Fibroid Treatment Portfolio Powers GYN Surgical Growth
by Moumi Mondal
Hologic's GYN Surgical segment gains momentum internationally as expanded fibroid treatments support growth.
JNJNegative Net Change MDTPositive Net Change HOLXNegative Net Change
medical medical-devices
Can ISRG Continue Its Strong Growth Amid Tariff & Rare Earth Woes?
by Indrajit Bandyopadhyay
ISRG's growth momentum faces pressure as tariffs and China's rare earth export curbs threaten margins and supply stability.
SYKPositive Net Change ISRGPositive Net Change GMEDPositive Net Change
medical medical-devices
New Strong Sell Stocks for Oct. 14th
by Zacks Equity Research
AR, BTCS and ATOS have been added to the Zacks Rank #5 (Strong Sell) List on October 14, 2025.
ATOSPositive Net Change ARPositive Net Change BTCSPositive Net Change
finance medical-devices oil-energy
BD Stock Down Despite Making Progress in the Treatment of PAD Lesions
by Zacks Equity Research
BDX advances PAD care with first patient enrolled in the XTRACT Registry using its dual-action Rotarex system.
BDXPositive Net Change RMDPositive Net Change MASINegative Net Change SOLVPositive Net Change
medical medical-devices
INSP Shares Down Despite Strong Clinical Data From Inspire V Trials
by Zacks Equity Research
Inspire Medical's Inspire V system shows strong safety, faster surgeries, and higher patient adherence in new trials.
MASINegative Net Change MMSIPositive Net Change WSTNegative Net Change INSPNegative Net Change
medical medical-devices
CVS' Aetna Wins Big on 2026 MA Star Ratings: How to Play the Stock?
by Moumi Mondal
CVS' Aetna shines in 2026 Medicare Star Ratings, with more than 81% of members in four-star plans, fueling a 73.5% YTD stock surge and strong investor momentum.
UNHPositive Net Change HUMPositive Net Change CVSPositive Net Change
medical medical-devices
Pulse Biosciences Unveils Promising First-in-Human Data for nPulse
by Zacks Equity Research
PLSE unveils strong first-in-human data for its nPulse Cardiac Surgical System, showcasing safety, speed, and durable AF treatment potential.
EWPositive Net Change MASINegative Net Change PLSENegative Net Change NDRANegative Net Change
medical medical-devices
BD Stock Down Despite Tie-Up to Boost Single-Cell Sequencing Workflow
by Zacks Equity Research
BDX teams with Opentrons to automate single-cell sequencing, advancing its multiomics and biosciences strategy.
BDXPositive Net Change RMDPositive Net Change MASINegative Net Change SOLVPositive Net Change
medical medical-devices
3 Medical Service Industry Stocks Poised to Counter Workforce Issues
by Urmimala Biswas
Here are three resilient medical services stocks, Labcorp, Charles River Laboratories and Teladoc, that are poised to outperform amid staffing shortages and digital healthcare growth.
LHPositive Net Change CRLNegative Net Change TDOCNegative Net Change
hospitals medical medical-devices smart-health
Here's Why You Should Retain PacBio Stock in Your Portfolio for Now
by Zacks Equity Research
PACB's Q2 beat, expanding Revio and Vega systems and growing clinical traction highlight its innovation-led recovery despite longer purchasing cycles.
MASINegative Net Change MMSIPositive Net Change WSTNegative Net Change PACBNegative Net Change
medical medical-devices
GE Healthcare Partners With Erasmus to Advance Precision Cancer Care
by Zacks Equity Research
GEHC's collaboration with Erasmus MC aims to advance precision oncology using next-gen total body PET/CT and AI imaging innovations.
MASINegative Net Change MMSIPositive Net Change WSTNegative Net Change GEHCNegative Net Change
medical medical-devices
FuelCell Energy (FCEL) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
FCELNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
A-Mark Precious Metals (AMRK) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
AMRKPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Grab These 4 Stocks With Solid Net Profit Margin to Maximize Returns
by Anirudha Bhagat
Let's take a look at four stocks, AVO, ELMD, GLDD and CENX, with stellar net profit margins and rising EPS estimates that can help create a winning portfolio.
ELMDNegative Net Change GLDDPositive Net Change CENXPositive Net Change AVOPositive Net Change
agriculture industrial-products medical medical-devices transportation
Ecolab Brings Direct-to-Chip Cooling Monitoring to Southeast Asia
by Zacks Equity Research
ECL debuts its 3D TRASAR direct-to-chip cooling monitoring in Singapore, boosting efficiency and sustainability in data centers.
ECLPositive Net Change MASINegative Net Change MMSIPositive Net Change WSTNegative Net Change
medical medical-devices
OMI Reshapes Portfolio With $375 Million Sale to Platinum Equity
by Zacks Equity Research
Owens & Minor sharpens its focus on home-based care with a $375M divestiture to Platinum Equity, unlocking cash, tax benefits, and long-term upside through a retained equity stake.
OMIPositive Net Change MASINegative Net Change MMSIPositive Net Change WSTNegative Net Change
medical medical-devices
Neogen Q1 Earnings Miss Estimates, Revenues Beat, Stock Climbs
by Zacks Equity Research
NEOG's Q1 earnings decline 42.9% year over year, while revenues of $209.2 million top the consensus mark.
BSXPositive Net Change NEOGPositive Net Change PODDNegative Net Change PAHCPositive Net Change
earnings medical medical-devices
The Launch of Foot and Ankle Trauma Solutions May Boost ZBH Stock
by Zacks Equity Research
Zimmer Biomet expands its foot & ankle trauma lineup with Gorilla Pilon Fusion & Phantom TTC Trauma Nail launches.
CAHPositive Net Change MASINegative Net Change PAHCPositive Net Change ZBHNegative Net Change
medical medical-devices
Are Options Traders Betting on a Big Move in Ardent Health Stock?
by Zacks Equity Research
Investors need to pay close attention to Ardent Health stock based on the movements in the options market lately.
ARDTNegative Net Change
medical medical-devices
ISRG Shares Rise as FDA Clears AI Integration for Ion Platform
by Zacks Equity Research
Intuitive Surgical shares climb after FDA clears AI-driven upgrades for its Ion platform, boosting precision and efficiency in lung biopsies.
ISRGPositive Net Change MASINegative Net Change MMSIPositive Net Change WSTNegative Net Change
medical medical-devices
Hims & Hers Expands Personalized Care Access Via Telehealth Platform
by Debanjana Dey
HIMS expands its AI-powered telehealth platform, boosting personalized care and eyeing international growth in 2026.
GDRXNegative Net Change HIMSNegative Net Change LFMDNegative Net Change
medical medical-devices